ASX - By Stock
|
RAC |
Re:
Link to the RAC AGM Webinar/Livestrean
|
|
LongTony
|
5 |
1.3K |
2 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
5
|
1.3K
|
2
|
|
ASX - By Stock
|
BSE |
Re:
Ann: Quarterly Activities Report - September 2023
|
|
LongTony
|
35 |
15K |
2 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
35
|
15K
|
2
|
|
ASX - By Stock
|
BSE |
Re:
Ann: 2023 LTIP cycle performance rights
|
|
LongTony
|
11 |
3.7K |
2 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
11
|
3.7K
|
2
|
|
ASX - By Stock
|
BSE |
Re:
Ann: 2023 LTIP cycle performance rights
|
|
LongTony
|
11 |
3.7K |
1 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
11
|
3.7K
|
1
|
|
ASX - By Stock
|
PRN |
Re:
Ann: Euroz Hartleys Industrial Forum Presentation
|
|
LongTony
|
16 |
5.4K |
3 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
16
|
5.4K
|
3
|
|
ASX - By Stock
|
PRN |
Re:
Ann: Euroz Hartleys Industrial Forum Presentation
|
|
LongTony
|
16 |
5.4K |
0 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
16
|
5.4K
|
0
|
|
ASX - By Stock
|
BSE |
Re:
Ann: 2023 LTIP cycle performance rights
|
|
LongTony
|
11 |
3.7K |
2 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
11
|
3.7K
|
2
|
|
ASX - By Stock
|
BSE |
Re:
Ann: 2023 LTIP cycle performance rights
|
|
LongTony
|
11 |
3.7K |
1 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
11
|
3.7K
|
1
|
|
ASX - By Stock
|
PRN |
Re:
Ann: Euroz Hartleys Industrial Forum Presentation
|
|
LongTony
|
16 |
5.4K |
2 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
16
|
5.4K
|
2
|
|
ASX - By Stock
|
BSE |
Re:
Ann: 2023 LTIP cycle performance rights
|
|
LongTony
|
11 |
3.7K |
1 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
11
|
3.7K
|
1
|
|
ASX - By Stock
|
PRN |
Re:
Ann: Euroz Hartleys Industrial Forum Presentation
|
|
LongTony
|
16 |
5.4K |
4 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
16
|
5.4K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
LongTony
|
508 |
130K |
40 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
508
|
130K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
LongTony
|
508 |
130K |
18 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
508
|
130K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
LongTony
|
508 |
130K |
17 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
130K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
LongTony
|
508 |
130K |
32 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
130K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
LongTony
|
508 |
130K |
18 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
130K
|
18
|
|
ASX - By Stock
|
PRN |
Re:
Ann: Euroz Hartleys Industrial Forum Presentation
|
|
LongTony
|
16 |
5.4K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
16
|
5.4K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
LongTony
|
508 |
130K |
15 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
130K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
LongTony
|
508 |
130K |
11 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
130K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Dr Daniel Tillett appointed CEO of Race Oncology
|
|
LongTony
|
120 |
35K |
56 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
120
|
35K
|
56
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
LongTony
|
226 |
57K |
16 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
57K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
LongTony
|
226 |
57K |
9 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
57K
|
9
|
|
ASX - By Stock
|
PRN |
Re:
Ann: Euroz Hartleys Industrial Forum Presentation
|
|
LongTony
|
16 |
5.4K |
13 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
16
|
5.4K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
LongTony
|
226 |
57K |
8 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
57K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Investor Briefing Invitation
|
|
LongTony
|
6 |
1.9K |
0 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
6
|
1.9K
|
0
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
LongTony
|
11K |
4.0M |
27 |
22/11/23 |
22/11/23 |
General
|
11K
|
4.0M
|
27
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
LongTony
|
11K |
4.0M |
13 |
22/11/23 |
22/11/23 |
General
|
11K
|
4.0M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of AGM & Proxy Form
|
|
LongTony
|
96 |
27K |
25 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
96
|
27K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of AGM & Proxy Form
|
|
LongTony
|
96 |
27K |
21 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
96
|
27K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race supports Study of Extramedullary AML
|
|
LongTony
|
50 |
20K |
19 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
50
|
20K
|
19
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
LongTony
|
11K |
4.0M |
47 |
20/11/23 |
20/11/23 |
General
|
11K
|
4.0M
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
LongTony
|
3K |
1.0M |
9 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
3K
|
1.0M
|
9
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
LongTony
|
11K |
4.0M |
20 |
19/11/23 |
19/11/23 |
General
|
11K
|
4.0M
|
20
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
LongTony
|
11K |
4.0M |
17 |
17/11/23 |
17/11/23 |
General
|
11K
|
4.0M
|
17
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
LongTony
|
11K |
4.0M |
38 |
17/11/23 |
17/11/23 |
General
|
11K
|
4.0M
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
LongTony
|
592 |
192K |
54 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
592
|
192K
|
54
|
|
ASX - By Stock
|
TSL |
Re:
Charts and Price Action
|
|
LongTony
|
2 |
1.5K |
1 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
2
|
1.5K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
LongTony
|
137 |
64K |
27 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
137
|
64K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
LongTony
|
137 |
64K |
36 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
137
|
64K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
LongTony
|
137 |
64K |
46 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
137
|
64K
|
46
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
LongTony
|
137 |
64K |
52 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
137
|
64K
|
52
|
|
ASX - By Stock
|
TSL |
Charts and Price Action
|
|
LongTony
|
2 |
1.5K |
3 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
2
|
1.5K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
LongTony
|
137 |
64K |
31 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
137
|
64K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
LongTony
|
137 |
64K |
103 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
137
|
64K
|
103
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
LongTony
|
22K |
7.7M |
54 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
22K
|
7.7M
|
54
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
LongTony
|
231 |
69K |
60 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
69K
|
60
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
LongTony
|
231 |
69K |
7 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
69K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
LongTony
|
231 |
69K |
8 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
69K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Meets Quality Specifications
|
|
LongTony
|
101 |
22K |
16 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
101
|
22K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
LongTony
|
231 |
69K |
19 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
231
|
69K
|
19
|
|